FPR1 and Stroke: FPR1 may be proved to be a reasonable target to induce neuroprotection in humans in future studies because FPR1 is expressed in activated cells 9 and blocking FPR1 may not affect baseline functions of monocytes and macrophages, a desirable situation for patients with stroke.